Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

CCMED_9_12_Infographic_Sep_18_2020 Staging and Testing for Stage III/IV Non-Small Cell Lung Cancer: Perspectives from Pathologists and Pulmonologists in US cancer care programs Improving pathologist and pulmonologist know-how on diagnostic modalities and alleviating barriers to care delivery can optimize care for stage III/IV NSCLC patients Accurate staging and testing using …
November 10, 2020
Lacy Sheets, MBA, Manager Revenue Cycle, St. Luke's Health System Rifeta Kajdic, Oncology Program Manager, St. Luke's Health System Gina Hampton, Revenue Application Specialist, St. Luke's Health System Effectively tracking patient applications for free medications or copay assistance can be an unwieldy, time-consuming, and frustrating task, putting patients at risk of falling through the cracks. By …
The Association of Cancer Care Centers (ACCC) has a long and successful history working with our national corporate partners to support them in better understanding the landscape of community oncology in today’s ever-changing healthcare environment. More specifically, ACCC helps our partners to better navigate the extraordinary challenges happening in oncology programs and practices through the lens …
Learn about the role of the interdisciplinary cancer team in managing oral chemotherapy for patients with cancer, and discover how one cancer program has improved their workflow while keeping the patient at the center.
Jeremy D. Kratz et al., UW Health, Madison, WI View Poster
Background Background Experience with 177Lu-Dotatate Therapy for Metastatic Neuroendocrine Cancer at a Quarternary Comprehensive Cancer Center Sich N, Kriley I, Chevinsky A, Sanchez F. Objective Determine the effectiveness of 177Lu-Dotatate therapy in a community cancer program through evaluation of clinical symptomatic response as well as RECIST criteria on serial imaging. …
PowerPoint Presentation Transition from chemotherapy (systemic) to radiotherapy (local) • CA19-9 trend may have utility in identifying distant disease in the absence of any radiologic or other indication of metastasis CA19-9 is the most important biomarker for PC1 • Normalization of CA19-9 during neoadjuvant treatment is associated with dramatically improved survival2 • Less …
PowerPoint Presentation A Phase I Trial of Neoadjuvant SBRT with Elective Nodal Radiation for Resectable Pancreas Cancer BACKGROUND RESULTS Pancreatic cancer (PDA) is a highly lethal malignancy with a high rate of local and regional relapse, even among patients with resectable disease. Prior data from randomized trials have indicated improved local control when adding radiation in the …
PowerPoint Presentation
PowerPoint Presentation
Nikhitha Chandrashekar, MD et al., UW Health, Madison, WI View Poster
Waterbirth_Kamps-Schmitt_Updated 4-30-20 ENDOCRINOPATHIES ASSOCIATED WITH IBRUTINIB – A RETROSPECTIVE ANALYSIS Nikhitha Chandrashekar, MD; Julia Shariff, MD; Daniel Short, MD, PhD, FACP, FACE INTRODUCTION CONCLUSIONS RESULTS ➢ Tyrosine Kinase Inhibitors (TKI) are used to for the targeted treatment of hematologic malignancies ➢ FDA approved indications for ibrutinib have been …
November 10, 2020
The APMC focuses primarily on providing education about APMs and other value-based care programs in cancer care.
1 ACCC Research Review: November 2020 Training for the Clinical Trials Workforce: A Message from the President's Task Force By Al B. Benson III, MD, FACP, FASCO This edition of the ACCC Research Review focuses on issues related to workforce training for cancer clinical research. Whether a cancer program is currently conducting clinical studies or is considering becoming a trial …
CCMED_7_10_Infographic_Oct_14_2020 Improving Non-Small Cell Lung Cancer Care Delivery: Learnings for Oncology Nurses and Patient Navigation From a National Quality Survey Aversano et al. (2020) How Patient Navigation Models in Non-Small Cell Lung Cancer Care Programs in the US Can Be Improved BREAST CANCER PROGRAM NAME SUPPORTING TEXT CAN GO HERE, MORE SUPPORT TEXT …